CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - MAGEE

NIH RePORTER · NIH · N01 · $15,432 · view on reporter.nih.gov ↗

Abstract

There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.

Key facts

NIH application ID
11166252
Project number
75N94020D00018-P00005-759402000001-1
Recipient
MAGEE-WOMEN'S RES INST AND FOUNDATION
Principal Investigator
BEATRICE CHEN, M.D., MPH
Activity code
N01
Funding institute
NIH
Fiscal year
2024
Award amount
$15,432
Award type
Project period
2020-08-01 → 2025-07-31